FDA Tracker
Regulatory status for every research peptide, updated monthly.
This site is for informational and research purposes only. It does not constitute medical advice. Peptides referenced are for laboratory research use only and are not intended for human consumption. Always consult a licensed physician before using any peptides.
| Peptide ▲ | FDA Status | Effective Date | Verified Date |
|---|---|---|---|
| 5-AMINO-1MQ | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| ADAMAX | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| ADIPOTIDE | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| AHK-CU | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| AICAR | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| AOD-9604 | Banned from Compounding | Mar 1, 2024 | Feb 1, 2026 |
| ARA-290 | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| ARGIRELINE (ACETYL HEXAPEPTIDE-3) | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| BPC-157 | Banned from Compounding | Mar 1, 2024 | Feb 1, 2026 |
| BPC-157 + TB-500 | Banned from Compounding | Mar 1, 2024 | Feb 1, 2026 |
| BRONCHOGEN | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| CAGRILINTIDE | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| CAGRILINTIDE + SEMAGLUTIDE | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| CARDIOGEN | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| CARTALAX | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| CEREBROLYSIN | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| CHONLUTEN | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| CJC-1295 | Compounding Allowed | Feb 1, 2026 | Feb 1, 2026 |
| CORTAGEN | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| DECAPEPTIDE-12 | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| DERMORPHIN | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| DIHEXA | Banned from Compounding | Mar 1, 2024 | Feb 1, 2026 |
| DS5 | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| DSIP | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| DULAGLUTIDE | FDA Approved | Sep 1, 2014 | Feb 1, 2026 |
| ELORALINTIDE | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| ENCLOMIPHENE | Compounding Allowed | Feb 1, 2026 | Feb 1, 2026 |
| EPITHALON | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| FOLLISTATIN | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| FOLLISTATIN 315 | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| FOLLISTATIN 344 | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| FOXO4-DRI | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| GHK | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| GHK-CU | Banned from Compounding | Mar 1, 2024 | Feb 1, 2026 |
| GHRP-2 | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| GHRP-6 | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| GLUTATHIONE | Compounding Allowed | Feb 1, 2026 | Feb 1, 2026 |
| GONADORELIN | FDA Approved | Feb 1, 2026 | Feb 1, 2026 |
| HEXARELIN | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| HGH FRAGMENT 176-191 | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| HUMANIN | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| IGF-1 DES | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| IGF-1 LR3 | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| IPAMORELIN | Compounding Allowed | Feb 1, 2026 | Feb 1, 2026 |
| KISSPEPTIN-10 | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| KPV | Banned from Compounding | Mar 1, 2024 | Feb 1, 2026 |
| LIRAGLUTIDE | FDA Approved | Dec 1, 2014 | Feb 1, 2026 |
| LIVAGEN | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| LL-37 | Banned from Compounding | Mar 1, 2024 | Feb 1, 2026 |
| MATRIXYL | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| MAZDUTIDE | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| MELANOTAN I | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| MELANOTAN II | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| MGF (Mechano Growth Factor) | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| MK-677 (IBUTAMOREN) | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| MOTS-C | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| NAD+ | Compounding Allowed | Feb 1, 2026 | Feb 1, 2026 |
| NONAPEPTIDE-1 | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| ORFORGLIPRON | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| OVAGEN | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| OXYTOCIN | FDA Approved | Feb 1, 2026 | Feb 1, 2026 |
| P21 | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| PAL-AHK | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| PAL-GHK | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| PALMITOYL DIPEPTIDE-6 | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| PANCRAGEN | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| PE-22-28 | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| PEG-MGF | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| PENTAPEPTIDE-18 | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| PGPIPN | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| PINEALON | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| PNC-27 | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| PROSTAMAX | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| PT-141 | FDA Approved | Jun 1, 2019 | Feb 1, 2026 |
| RETATRUTIDE | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| RIGIN | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| SELANK | Banned from Compounding | Mar 1, 2024 | Feb 1, 2026 |
| SEMAGLUTIDE | FDA Approved | Jun 1, 2021 | Feb 1, 2026 |
| SEMAX | Banned from Compounding | Mar 1, 2024 | Feb 1, 2026 |
| SERMORELIN | Compounding Allowed | Feb 1, 2026 | Feb 1, 2026 |
| SLU-PP-332 | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| SNAP-8 | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| SOMATROPIN (HGH) | FDA Approved | Feb 1, 2026 | Feb 1, 2026 |
| SS-31 (ELAMIPRETIDE) | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| SURVODUTIDE | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| SYN-AKE | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| SYN-COLL | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| TB-500 | Banned from Compounding | Mar 1, 2024 | Feb 1, 2026 |
| TESAMORELIN | FDA Approved | Nov 1, 2010 | Feb 1, 2026 |
| TESOFENSINE | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| TESTAGEN | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| THYMAGEN | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| THYMALIN | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| THYMOSIN ALPHA-1 | Banned from Compounding | Mar 1, 2024 | Feb 1, 2026 |
| TIRZEPATIDE | FDA Approved | Nov 1, 2023 | Feb 1, 2026 |
| TRIPEPTIDE-29 | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| TRIPTORELIN | FDA Approved | Feb 1, 2026 | Feb 1, 2026 |
| VESILUTE | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| VESUGEN | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| VIALOX | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| VILON | Research Only | Feb 1, 2026 | Feb 1, 2026 |
| VIP | Research Only | Feb 1, 2026 | Feb 1, 2026 |